7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 
      
    		                          
      cash flows from operating activities:
    		                          
      net income
    		10,219,000 -5,154,000 -4,425,000 -6,601,000 -4,111,000 -9,692,000 -4,056,000 -17,333,000 -8,127,000 -13,073,000 -8,213,000 -37,389,000 -8,961,000 -7,454,000 -9,020,000 -9,558,000 -6,534,000 -7,375,000 -7,126,000 -6,437,000 -6,537,000 -9,042,000 -3,927,000 -3,052,000 -4,512,000 2,473,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                          
      depreciation and amortization
    		21,000 22,000 14,000 23,000 23,000 24,000 21,000 22,000 466,000 52,000 47,000             41,000 41,000 45,000 
      stock-based compensation
    		251,000 306,000 305,000 382,000 285,000 791,000 744,000 781,000 770,000 1,622,000 1,629,000 1,544,000 2,443,000 1,281,000 1,148,000 1,566,000 1,689,000 1,513,000 1,939,000 1,739,000 1,530,000 252,000     
      non-cash lease expense
    		101,000 100,000 96,000 97,000 116,000 111,000 110,000 133,000 174,000 172,000 169,000 166,000 170,000 -62,000 179,000 179,000 177,000          
      loss on impairment of goodwill
    		 0 0 2,574,000 484,000 534,000 454,000                    
      gain on debt extinguishment
    		-14,520,000                          
      unrealized (gain) loss on foreign exchange rate changes
    		-209,000     231,000 -456,000                    
      changes in assets and liabilities:
    		                          
      prepaid expenses and other current assets
    		270,000 480,000 311,000 -86,000 218,000 389,000 191,000 257,000 239,000 683,000 503,000 -158,000 337,000 502,000 427,000 234,000 -16,000 299,000 457,000 -73,000 5,000 279,000 -2,000 -268,000 293,000 -174,000 
      accounts payable
    		880,000 -135,000 -20,000 211,000 504,000 -161,000 -662,000 348,000 31,000 111,000 294,000 -651,000 -222,000 435,000 -497,000 -178,000 -307,000 345,000 -117,000 -693,000 -2,003,000 -474,000 261,000 -425,000 1,635,000 -722,000 
      accrued expenses
    		328,000 -251,000 135,000 114,000 68,000 -940,000 -322,000 -727,000 151,000 -143,000 439,000 -634,000 -69,000 -468,000 628,000 663,000 -238,000 -2,025,000 560,000 -608,000 -1,118,000 -208,000 80,000 118,000 -266,000 -1,168,000 
      operating lease liabilities
    		-113,000 -93,000 -106,000 -105,000 -127,000 -120,000 -123,000 -145,000 -183,000 -16,000 -180,000 -176,000 -176,000 43,000 -194,000 -197,000 -190,000 -190,000 -319,000 -251,000 -214,000      
      other current liabilities
    		-175,000                          
      net cash from operating activities
    		-2,947,000 -3,567,000 -3,854,000 -3,497,000 -2,519,000 -3,380,000 -4,099,000 -5,258,000 -6,715,000 -4,932,000 -5,281,000 -7,403,000 -6,048,000 -4,539,000 -8,256,000 -7,038,000 -5,482,000 -5,459,000 -3,824,000 -6,621,000 -8,759,000 -6,191,000 -3,278,000 -3,766,000 -2,546,000 -4,808,000 
      capex
    		0 0 0 0 0 0 0 -10,000 -3,000 -173,000 -103,000 0 0 -264,000 -15,000 0 0 -62,000 97,000 -152,000 -74,000 0 0 0 0 0 
      free cash flows
    		-2,947,000 -3,567,000 -3,854,000 -3,497,000 -2,519,000 -3,380,000 -4,099,000 -5,268,000 -6,718,000 -5,105,000 -5,384,000 -7,403,000 -6,048,000 -4,803,000 -8,271,000 -7,038,000 -5,482,000 -5,521,000 -3,727,000 -6,773,000 -8,833,000 -6,191,000 -3,278,000 -3,766,000 -2,546,000 -4,808,000 
      cash flows from financing activities:
    		                          
      proceeds from atm program, net of issuance costs
    		1,367,000     1,493,000 1,535,000 1,020,000 205,000                  
      principal payments on loans payable
    		-233,000 -234,000 -233,000 -78,000 -252,000 -377,000 -378,000 -125,000 -294,000 -441,000 -440,000 -2,639,000 -352,000              
      payments on debt extinguishment
    		-100,000                          
      proceeds from exercise of common stock warrants, net of expenses
    		 0 0 0 843,000                      
      net cash from financing activities
    		1,034,000 521,000 -233,000 10,716,000 591,000 1,116,000 1,157,000 895,000 -89,000 2,912,000 -40,000 -1,119,000 27,608,000 48,000 -1,137,000 21,246,000 -199,000     30,417,000 3,279,000 2,542,000 2,500,000 4,871,000 
      net decrease in cash, cash equivalents, and restricted cash
    		-1,913,000    -1,928,000                      
      cash, cash equivalents, and restricted cash - beginning of period
    		4,469,000  0 0 6,326,000  0 0 22,502,000  0 0 17,084,000              
      cash, cash equivalents, and restricted cash - end of period
    		2,556,000  -4,102,000 7,219,000 4,398,000  -2,942,000 -4,163,000 15,695,000  -5,424,000 -8,525,000 38,644,000              
      supplementary disclosure of non-cash activity:
    		                          
      fair value of common stock consideration related to debt extinguishment
    		280,000                          
      fair value of january 2023 warrant modifications related to the january 2023 warrant exercise inducement
    		 0 0 0 1,238,000                      
      fair value of february 2023 warrant modifications related to the february 2023 warrant exercise inducement
    		 0 0 0 274,000                      
      see notes to condensed consolidated financial statements
    		                          
      loss on impairment of intangible assets
    		         7,250,000 0                
      loss on sale and disposal of property and equipment
    		 0    0 0                    
      deferred income tax benefit
    		         -1,655,000 0                
      unrealized gain on foreign exchange rate changes
    		 258,000 -176,000 -106,000 21,000    -236,000    -109,000              
      cash flows from investing activities:
    		                          
      proceeds from sale of property and equipment
    		     0 0               0 0    
      purchase of property and equipment
    		 0    0 0 -10,000 -3,000 -173,000 -103,000   -264,000 -15,000   -62,000 97,000 -152,000 -74,000     0 
      net cash from investing activities
    		 0    0 0 200,000 -3,000 -173,000 -103,000   -264,000 -15,000   -62,000 2,597,000 10,837,000 425,000 -13,736,000 0   0 
      proceeds from issuance of common stock and warrants, net of issuance costs
    		 0 0       0 0 0 27,390,000 0 0            
      cash, cash equivalents, and restricted cash - beginning of year
    		                          
      cash, cash equivalents, and restricted cash - end of year
    		                          
      prepayment of insurance through third-party financing
    		 0 0   0 0   0 0                
      net increase in cash, cash equivalents, and restricted cash
    		  -4,102,000   -2,264,000 -2,942,000 -4,163,000 -6,807,000 -2,193,000 -5,424,000 -8,525,000 21,560,000              
      non-cash expense related to equity consideration for a service agreement
    		         0 0 0 494,000              
      proceeds from research and development funding arrangement
    		         200,000 400,000   400,000 1,400,000            
      operating lease liabilities arising from obtaining right-of-use assets
    		         141,000 0 0 2,000,000              
      non-cash expense related to warrant modifications
    		             0 0            
      unrealized loss on foreign exchange rate changes
    		         65,000 31,000                
      collaboration and device development payable
    		             0 -968,000 -899,000 -108,000 63,000 357,000 -495,000 -692,000      
      proceeds from atm program, net of expenses
    		         3,153,000 0               0 
      proceeds from exercise of common stock warrants
    		             0             
      proceeds from paycheck protection program loan
    		                          
      principal payments on paycheck protection program loan
    		                          
      effect of exchange rate changes on cash and cash equivalents
    		              249,000 520,000 -98,000  -113,000 -136,000 -202,000      
      depreciation
    		            45,000 42,000 41,000 40,000 42,000 17,000 39,000 89,000 50,000 38,000     
      amortization of debt discount
    		             0 0 0 3,000 36,000 35,000 37,000 55,000 560,000     
      changes in:
    		                          
      proceeds from the atm program, net of expenses
    		            570,000              
      net income on extinguishment of debt
    		                          
      recognition of deferred revenue
    		                 0 0 -158,000 -40,000   -356,000 -204,000  
      realized gain on investments
    		                  -14,000 -50,000 -11,000      
      other liabilities
    		                 -112,000 60,000 35,000 24,000      
      proceeds from sale of marketable securities
    		                  2,500,000 10,989,000 499,000      
      proceeds from payroll protection program loan
    		             0 0            
      principal payments on payroll protection program loan
    		                          
      proceeds from private placement issuance of securities, net of expenses
    		                     30,352,000 -1,000   6,071,000 
      proceeds from loan payable, net of expenses
    		                     1,880,000 1,780,000 0 2,500,000  
      payments for taxes related to net share settlements of restricted stock units
    		                          
      principle payments on payroll protection program loan
    		              0            
      principle payments on loans payable
    		              -2,678,000 0 -199,000          
      payment for taxes related to net share settlements of restricted stock units
    		                  0 0 -151,000      
      prepayment of insurance through 3rd party financing
    		              0            
      net increase in cash, cash equivalents and restricted cash
    		                          
      cash, cash equivalents and restricted cash - beginning of period
    		               0 22,732,000  0        
      cash, cash equivalents and restricted cash - end of period
    		               14,716,000 16,953,000  -1,686,000        
      net decrease in cash and cash equivalents
    		                -5,779,000  -1,686,000 4,053,000 -9,134,000      
      net realized gain on sale of marketable securities
    		                          
      gain on sale of equipment
    		                          
      sale of marketable securities
    		                          
      purchase of marketable securities
    		                          
      cash acquired in cvie acquisition
    		                          
      repayment of loan payable
    		                          
      proceeds from convertible note payable
    		                     0     
      repayment of convertible note payable
    		                          
      effect of exchange rates on cash and cash equivalents
    		                          
      net increase/(decrease) in cash and cash equivalents
    		                      2,000 -1,216,000 -46,000 63,000 
      cash, cash equivalents and restricted cash - beginning of year
    		                    11,358,000 0 0 0 2,040,000 0 
      cash, cash equivalents and restricted cash - end of year
    		                    2,224,000 10,578,000 2,000 -1,216,000 1,994,000 63,000 
      amortization of operating lease right-of-use assets
    		                  305,000 244,000 192,000      
      gain on sale of property and equipment
    		                      0    
      net cash (used in) / provided by financing activities
    		                  -346,000 -27,000 -598,000      
      prepayment of director and officer insurance through 3rd party financing
    		                  0        
      principle payments on loan payable
    		                   -27,000 -447,000      
      amortization of prepaid interest
    		                         94,000 
      gain on debt restructuring
    		                          
      deferred revenue - current
    		                          
      deferred revenue - non-current
    		                          
      principal payments on debt restructuring
    		                          
      effect of exchange rates on cash
    		                          
      net increase/(decrease) in cash, cash equivalents and restricted cash
    		                          
      supplementary disclosure of cash flows information:
    		                          
      interest paid
    		                         574,000 
      collaboration payable
    		                      52,000 45,000 49,000 -559,000 
      deferred revenue
    		                          
      stock-based compensation and 401(k) plan employer match
    		                       140,000 418,000 816,000 
      fair value adjustment of common stock warrants
    		                          
      loss on sale or disposal of equipment
    		                          
      gain/(loss) on sale or disposal of equipment
    		                          
      proceeds from loan payable
    		                          
      stock–based compensation and 401(k) plan employer match
    		                          
      loss / (gain) on disposal of equipment
    		                          
      inventory
    		                          
      other assets
    		                          
      other liabilities and accrued interest on loan payable
    		                          
      proceeds from issuance of securities, net of expenses
    		                          
      proceeds from exercise of stock options
    		                          
      principal payments of loan payable
    		                          
      principal payments under equipment loan and capital lease obligations
    		                          
      net increase in cash and cash equivalents
    		                          
      cash and cash equivalents as of beginning of year
    		                          
      cash and cash equivalents as of end of year
    		                          
      equipment acquired through capitalized lease
    		                          
      cash flow from operating activities:
    		                          
      stock–based compensation and 401(k) match
    		                          
      loss / (gain) on sale of equipment
    		                          
      cash flow from investing activities:
    		                          
      cash flow from financing activities:
    		                          
      cash and cash equivalents – beginning of year
    		                          
      cash and cash equivalents – end of year
    		                          
      non-cash transactions:
    		                          
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.